DCF Valuation: The Stock Market Sanity Check For most

New Post Public Reply Private Reply Replies (0) Message Board

Dec 2, 2012 at 8:03 AM

DCF Valuation: The Stock Market Sanity Check For most people, discounted cash flow (DCF) valuation seems like a form of financial black art, best left to Ph.D.s and Wall Street technical wizards. DCF intricacies do involve complex math and financial modeling, but if you understand the basic concepts behind DCF, you can perform "back-of-the-envelope" calculations to help you make investment decisions or value small businesses. This article, will discuss a few practical applications. DCF Usages Let's begin with a brief overview. DCF is a valuation method that can be used for privately-held companies. It projects a series of future cash flows, EBITDA or earnings and then discounts for the time value of money, typically using the company's own weighted average cost of capital (WACC) over a period of five to 10 years. The sum of all future discounted flows is the company's present value. Professional business appraisers often include a terminal value at the end of the projected earnings period, and they also may apply discounts for small-company risk, lack of liquidity or shares representing a minority interest in the company. An Acid Test for Valuing a Public Stock DCF is a blue-ribbon standard for valuing privately-held companies; it can also be used as an acid test for publicly-traded stocks . Public companies in the United States may have P/E ratios (determined by the market) that are higher than DCF. This is especially true of smaller, younger companies with high costs of capital, and uneven or uncertain earnings or cash flow. But it also can be true of large, successful companies with astronomical P/E ratios. For example, let's do a simple DCF test to check whether Apple stock was fairly valued at a given point in time. During June of 2008, Apple had a market capitalization of $150 billion. The company was generating operating cash flow of around $7 billion per year and we'll assign a WACC of 7% to the company, because it is financially strong and can raise equity and debt capital inexpensively. We'll also assume that Apple can increase its operating cash flow by 15% per year over the 10-year period, a somewhat aggressive assumption because few companies are capable of sustaining such high growth rates over lengthy periods. On this basis, DCF would value Apple at a market capitalization of $106.3 billion, 30% below its stock market price at the time. In this case, DCF provides one indication that the market may be paying too high of a price for Apple common stock. Smart investors might look to other indicators, such as inability to sustain cash flow growth rates in the future, for confirmation. The Importance of WACC on Stock Market Valuations Doing just a few DCF calculations demonstrates the link between a company's cost of capital and its valuation. For large public companies (such as Apple), the cost of capital tends to be somewhat stable. But for small companies, this cost can fluctuate significantly over economic and interest rate cycles. The higher a company's cost of capital, the lower its DCF valuation will be. For the smallest companies (below about $500 million in market cap), DCF technicians may add a "size premium" of 2-4% to the company's WACC to account for extra risk. During the credit crunch of 2007 and 2008, the cost of capital for the smallest public companies soared as banks tightened lending standards. Some small public companies that could tap bank credit at 8% in 2006 suddenly had to pay 12-15% to hedge funds for increasingly-scarce capital. Using simple DCF valuation, let's see what the impact of increasing WACC from 8% to 14% would be on a small public company with $10 million in annual cash flow and projected annual cash flow growth of 12% over a 10-year period. Net present value of the company @ 8% WACC $143.6 million Net present value of the company @ 14% WACC $105.0 million Decline in net present value $ $38.6 million Decline in net present value % 26.9% Based on the higher cost of capital, the company is valued at $38.6 million less, representing a 26.9% decline in value. Building a Company's Value If you are building a small company and hope to sell it one day, DCF valuation can help you focus on what is most important - generating steady growth on the bottom line. In many small companies, it's difficult to project cash flow or earnings years into the future, and this is especially true of companies with fluctuating earnings or exposure to economic cycles. A business valuation expert is more willing to project growing cash flows or earnings over a lengthy period when the company has already demonstrated this ability. Another lesson taught by DCF analysis is to keep your balance sheet as clean as possible by avoiding excessive loans or other forms of leverage. Awarding stock options or deferred compensation plans to a company's top executives can strengthen a company's appeal to attract quality management, but it can also create future liabilities that will increase the company's cost of capital. The Bottom Line DCF valuation isn't just financial rocket science. It also has practical applications that can make you a better stock market investor because it serves as an acid test of what a public company would be worth if it were valued the same as comparable private companies. Astute, value-minded investors use DCF as one indicator of value, and also as a "safety check" to avoid paying too much for shares of stock, or even a whole company.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Resorts World NYC Unveils Luxe High-Roller Room

New Frontier for New York's Gaming Scene The glitz and glamour of high-roller gaming just found a new home in the heart of Queens. Resorts World New York City (RWNYC), which has been turning heads for over a decade, has now cranked the luxe up a notch with the introduction of its International Room. This isn't just any room, folks; we're talking about a high-limit gaming...

Voter Power Flexes with Early Voting Celebrations

Voter Engagement Hits a New High with Nationwide Parties Well, look at that—voter turnout's got its own party scene now, and it's making waves. As Vote Early Day approaches, the folks at When We All Vote are cranking up the volume on civic engagement with what's touted as the biggest Party at the Polls program yet. With almost 700 get-togethers riffing across the U.S.,...

Unicycive's Stock Plunge: Fraud Suit and FDA Hurdles

Unicycive's Tumultuous Journey Lately, it's been a rocky road for Unicycive Therapeutics, Inc., with their stock free-falling 39.1% in the span of a heartbeat on June 30, 2026. What sparked this nosedive? The FDA kicked back their revised New Drug Application for a kidney disease treatment yet again, spotlighting old manufacturing issues never nipped in the bud. Talk...

Rakuten Medical's Long-Term Data Shows Promise

This Isn't Just Another Cancer Update Alright, folks, let's unwrap what's happening today with Rakuten Medical. They've thrown some serious numbers into the ring at the ESMO Congress 2026 in Madrid. We're talking long-term follow-up results of their ASP-1929 photoimmunotherapy combined with pembrolizumab in tackling recurrent and metastatic head and neck squamous cell...

Ruth, Mickey, Superman: Morphy's Auction Smorgasbord

A Surreal Gathering of Icons and Memorabilia Who'd have thought you could snag both Babe Ruth and Mickey Mouse in one fell swoop? Well, come November 10-12, 2026, fans and collectors alike will have the opportunity at Morphy Auctions in Denver, PA. It's a dizzying array of Americana where cultural legend meets sports royalty, and we're not talking pocket change here. Babe...

Venture Dock Fosters Global Startup Ecosystems

Venture Dock Connects the Global Startup Dots When it comes down to bridging the gap between promising innovation and commercial success, you'd be hard-pressed to find a better player than Venture Dock. In a world filled with buzzwords and fluff, these guys are socketed deep in the guts of genuine startup development — and they're making waves with their recent...

D-Wave Investors Face Pressure Ahead of December 15

Investors Eye December 15 Deadline Nothing like a looming deadline to stir up some anxiety among investors, and that's exactly what's going down at D-Wave Quantum Inc. right now. We're talking about the class action lawsuit spearheaded by the firm Robbins Geller Rudman & Dowd LLP. They've sent out a call to arms for investors who suffered significant losses from February...

First Citizens Surprises with Q3 Gains and Buyback Plan

Unexpected Third Quarter Tailwinds for First Citizens There are days in this trading gig when a bank I'll barely sneeze at hits out of the park. First Citizens BancShares (NASDAQ:FCNCA) pulled off such a feat, wringing out a third-quarter 2026 performance that beat their own benchmarks. They threw $600 million back to shareholders in repurchased stocks while repaying an...

California Waste Solutions: Investing in Vietnam's Future

Some folks see trash. David Duong sees hope—and dollar signs. This man ain't just talking trash collection; he's flipping waste into opportunity and, more importantly, into core community building in Vietnam. Over at Vietnam Waste Solutions, a subsidiary of California Waste Solutions, they're blending environmental breakthroughs with good old-fashioned community values....

Kahn Swick & Foti Questions Valaris Transocean Deal

Valaris and Transocean: A Closer Look at the Deal Diving right into it, folks, we've got Kahn Swick & Foti, LLC taking a hard look at the proposed sale of Valaris Limited over to Transocean Ltd. Now, on paper, this might seem like another run-of-the-mill corporate shuffle, but not so fast. There're a few rocky waters here that might make even the hardest boiled of us...